Zobrazeno 1 - 10
of 228
pro vyhledávání: '"Enzyme Inhibitors/*pharmacology"'
Autor:
Lawler, P.R., Derde, L.P.G., Veerdonk, F.L. van de, McVerry, B.J., Huang, D.T., Berry, L.R., Lorenzi, E., Kimmenade, R.R.J. van, Gommans, F., Vaduganathan, M., Leaf, D.E., Baron, R.M., Kim, E.Y., Frankfurter, C., Epelman, S., Kwan, Y., Grieve, R., O'Neill, S., Sadique, Z., Puskarich, M., Marshall, J.C., Higgins, A.M., Mouncey, P.R., Rowan, K.M., Al-Beidh, F., Annane, D., Arabi, Y.M., Au, C., Beane, A., Bentum-Puijk, W. van, Bonten, M.J.M., Bradbury, C.A., Brunkhorst, F.M., Burrell, A., Buzgau, A., Buxton, M., Cecconi, M., Cheng, A.C., Cove, M., Detry, M.A., Estcourt, L.J., Ezekowitz, J., Fitzgerald, M., Gattas, D., Godoy, L.C., Goossens, H., Haniffa, R., Harrison, D.A., Hills, T., Horvat, C.M., Ichihara, N., Lamontagne, F., Linstrum, K.M., McAuley, D.F., McGlothlin, A., McGuinness, S.P., McQuilten, Z., Murthy, S., Nichol, A.D., Owen, D.R.J., Parke, R.L., Parker, J.C., Pollock, K.M., Reyes, L.F., Saito, H., Santos, M.S., Saunders, C.T., Seymour, C.W., Shankar-Hari, M., Singh, V., Turgeon, A.F., Turner, A.M., Zarychanski, R., Green, C., Lewis, R.J., Angus, D.C., Berry, S., Gordon, A.C., McArthur, C.J., Webb, S.A.
Publikováno v:
Lawler, P R, Derde, L P G, Van De Veerdonk, F L, McVerry, B J, Huang, D T, Berry, L R, Lorenzi, E, Van Kimmenade, R, Gommans, F, Vaduganathan, M, Leaf, D E, Baron, R M, Kim, E Y, Frankfurter, C, Epelmaņ, S, Kwan, Y, Grieve, R, O'Neill, S, Sadique, Z, Puskarich, M, Marshall, J C, Higgins, A M, Mouncey, P R, Rowan, K M, Al-Beidh, F, Annane, D, Arabi, Y M, Au, C, Beane, A, Van Bentum-Puijk, W, Bonten, M J M, Bradbury, C A, Brunkhorst, F M, Burrell, A, Buzgau, A, Buxton, M, Cecconi, M, Cheng, A C, Cove, M, Detry, M A, Estcourt, L J, Ezekowitz, J, Fitzgerald, M, Gattas, D, Godoy, L C, Goossens, H, Haniffa, R, Harrison, D A, Hills, T, Horvat, C M, Ichihara, N, Lamontagne, F, Linstrum, K M, McAuley, D F, McGlothlin, A, McGuinness, S P, McQuilten, Z, Murthy, S, Nichol, A D, Owen, D R J, Parke, R L, Parker, J C, Pollock, K M, Reyes, L F, Saito, H, Santos, M S, Saunders, C T, Seymour, C W, Shankar-Hari, M, Singh, V, Turgeon, A F, Turner, A M, Zarychanski, R, Green, C, Lewis, R J, Angus, D C, Berry, S, Gordon, A C, McArthur, C J & Webb, S A 2023, ' Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with Covid-19. A randomized clinical trial ', JAMA, vol. 329, no. 14, pp. 1183-1196 . https://doi.org/10.1001/jama.2023.4480
Jama : Journal of the American Medical Association, 329, 14, pp. 1183-1196
Jama : Journal of the American Medical Association, 329, 1183-1196
Jama : Journal of the American Medical Association, 329, 14, pp. 1183-1196
Jama : Journal of the American Medical Association, 329, 1183-1196
Contains fulltext : 291878.pdf (Publisher’s version ) (Closed access) IMPORTANCE: Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. OBJECTIVE: To determine whether angiotensin-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8ff6a211c4c42dc02259195c83981b0d
https://pure.qub.ac.uk/en/publications/8cae3556-8039-49ea-a414-6da1b5a01052
https://pure.qub.ac.uk/en/publications/8cae3556-8039-49ea-a414-6da1b5a01052
Autor:
Giulia Franciosa, Jesper V. Olsen
Publikováno v:
Franciosa, G & Olsen, J V 2023, ' Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors ', OncoTarget, vol. 14, pp. 281-283 . https://doi.org/10.18632/oncotarget.28392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b600517b73be7f6aea170398ffae5573
https://curis.ku.dk/portal/da/publications/impact-of-shp2-tyrosine-phosphorylation-on-the-development-of-acquired-resistance-to-allosteric-shp2-inhibitors(ca2d5b9b-3d94-46d2-9081-c5b372fdd0c6).html
https://curis.ku.dk/portal/da/publications/impact-of-shp2-tyrosine-phosphorylation-on-the-development-of-acquired-resistance-to-allosteric-shp2-inhibitors(ca2d5b9b-3d94-46d2-9081-c5b372fdd0c6).html
Autor:
Barbara Tomic, Tomislav Smoljo, Hrvoje Lalic, Vilma Dembitz, Josip Batinic, Drago Batinic, Antonio Bedalov, Dora Visnjic
Acute myeloid leukemia (AML) is characterized by arrested differentiation making differentiation therapy a promising treatment strategy. Recent success of inhibitors of mutated isocitrate dehydrogenase (IDH) invigorated interest in differentiation th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d328b03c9280a3fbd95f7362c438e671
https://www.bib.irb.hr/1211738
https://www.bib.irb.hr/1211738
Autor:
Paulina Biniecka, Saki Matsumoto, Axel Belotti, Jessie Joussot, Jian Fei Bai, Somi Reddy Majjigapu, Paul Thoueille, Dany Spaggiari, Vincent Desfontaine, Francesco Piacente, Santina Bruzzone, Michele Cea, Laurent A. Decosterd, Pierre Vogel, Alessio Nencioni, Michel A. Duchosal, Aimable Nahimana
Publikováno v:
Molecules
Volume 28
Issue 4
Pages: 1897
Molecules, vol. 28, no. 4, pp. 1897
Volume 28
Issue 4
Pages: 1897
Molecules, vol. 28, no. 4, pp. 1897
Targeting cancer cells that are highly dependent on the nicotinamide adenine dinucleotide (NAD+) metabolite is a promising therapeutic strategy. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme catalyzing NAD + production. D
Autor:
Erwan Le Grognec, Carmen Ortiz Mellet, Alexandre Lumbroso, M. Isabel García-Moreno, Clément Berthonneau, Aurélien Planchat, Isabelle Beaudet, Jean-Paul Quintard
Publikováno v:
Organic and Biomolecular Chemistry
Organic and Biomolecular Chemistry, Royal Society of Chemistry, 2021, 19 (5), pp.1083-1099. ⟨10.1039/d0ob02249g⟩
Organic and Biomolecular Chemistry, Royal Society of Chemistry, 2021, 19 (5), pp.1083-1099. ⟨10.1039/d0ob02249g⟩
International audience; A highly enantioselective synthesis of (R,S) or (S,S)-2,6-disubstituted dehydropiperidines has been previously achieved through Sn/Li transmetalation of the corresponding stannylated dehydropiperidines or of their precursors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f7d08bfb233a3d16e4bf48692fb1e3
https://hal.archives-ouvertes.fr/hal-03388809/document
https://hal.archives-ouvertes.fr/hal-03388809/document
Autor:
Maciej Tomaszewski, Louise M Burrell, Stephen Harrap, Damian Skrypnik, Eddie Cano-Gamez, Sean G. Byars, Adam Greenstein, Maciej Glyda, Anthony M. Heagerty, Michelle C. Maier, Priscilla R. Prestes, Andrzej Antczak, Fadi J. Charchar, Xiao Jiang, Joanna Zywiec, Andrew P. Morris, Matthew Denniff, Bernard Keavney, Gosia Trynka, David Scannali, Xiaoguang Xu, Paweł Bogdański, Adrian S. Woolf, Alicja Nazgiewicz, Ewa Zukowska-Szczechowska, Wojciech Wystrychowski, James Eales, Bryan Williams, Tomasz J. Guzik, Nilesh J. Samani, Robert Król, Sushant Saluja, Monika Szulińska
Publikováno v:
Jiang, X, Eales, J M, Scannali, D, Nazgiewicz, A, Prestes, P, Maier, M, Denniff, M, Xu, X, Saluja, S, Cano-Gamez, E, Wystrychowski, W, Szulinska, M, Antczak, A, Byars, S, Skrypnik, D, Glyda, M, Król, R, Zywiec, J, Zukowska-Szczechowska, E, Burrell, L M, Woolf, A S, Greenstein, A, Bogdanski, P, Keavney, B, Morris, A P, Heagerty, A, Williams, B, Harrap, S B, Trynka, G, Samani, N J, Guzik, T J, Charchar, F J & Tomaszewski, M 2020, ' Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney ', European Heart Journal, vol. 41, no. 48, pp. 4580-4588 . https://doi.org/10.1093/eurheartj/ehaa794
Eur Heart J
European Heart Journal
Eur Heart J
European Heart Journal
Aims Angiotensin-converting enzyme 2 (ACE2) is the cellular entry point for severe acute respiratory syndrome coronavirus (SARS-CoV-2)—the cause of coronavirus disease 2019 (COVID-19). However, the effect of renin-angiotensin system (RAS)-inhibitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481d135a224eaa582028c5e25333c9d8
http://www.scopus.com/inward/record.url?scp=85099324025&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85099324025&partnerID=8YFLogxK
Autor:
Maria C. Cid, Sander Willox, Elizabeth A. V. Jones, Giusy Di Conza, Donatella Ponti, Rosa Martín-Pérez, Roser Alba-Rovira, Ward Celus, Massimiliano Mazzone, Manuel Ehling
Publikováno v:
Circ Res
Circulation Research, 127(6), 707-723. LIPPINCOTT WILLIAMS & WILKINS
Circulation Research, 127(6), 707-723. LIPPINCOTT WILLIAMS & WILKINS
Rationale: How endothelial cells (ECs) migrate and form an immature vascular plexus has been extensively studied. Yet, mechanisms underlying vascular remodeling remain poorly established. A better understanding of these processes may lead to the desi
Publikováno v:
Cells, Vol 9, Iss 1613, p 1613 (2020)
HOX genes are commonly known for their role in embryonic development, defining the positional identity of most structures along the anterior-posterior axis. In postembryonic life, HOX gene aberrant expression can affect several processes involved in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f8e7bb5f041ab8825d27662dd2ec2a
https://hdl.handle.net/10216/143517
https://hdl.handle.net/10216/143517
Autor:
Izzettin Hatip-Al-Khatib, Funda F. Bölükbaşı Hatip, Junichi Matsumoto, Fuyuko Takata, Takashi Machida, Yasufumi Kataoka, Shinya Dohgu, Atsushi Yamauchi
Publikováno v:
Brain Research. 1692:34-44
Interleukin (IL)-6 is an important mediator of neurovascular dysfunction, neurodegeneration and/or neuroinflammation. We previously reported that brain pericytes released higher levels of IL-6 than did glial cells (astrocytes and microglia) in respon
Autor:
Frederik H. Verbrugge, Pieter Martens, Wilson W.H. Tang, Philippe Bertrand, Matthias Dupont, Petra Nijst, Wilfried Mullens
Publikováno v:
Journal of Cardiac Failure. 23:597-605
Background Cardiac resynchronization therapy (CRT) improves mortality and morbidity on top of optimal medical therapy in heart failure with reduced ejection fraction (HFrEF). This study aimed to elucidate the association between neurohumoral blocker